Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors
This study is testing a program called ASCENT to help cancer survivors manage their pain better. Cancer pain can be a big problem for many people, and this study aims to find new ways to help. You might be able to join if you are 18 or older, have a history of certain cancers (like lymphoma, myeloma, or other solid tumors) treated at a participating Mayo site in the last 15 years, and have a pain score of 5 or higher that started or worsened after your cancer diagnosis. You also need to fit the description of being rural or Hispanic. The study will look at how much your pain score changes over 6 months. Currently, the study's status is unclear, but it plans to enroll 660 people.
- Study design
- This study is interventional and will involve 660 participants. You will be randomly assigned to one of two groups: either receiving enhanced usual care with the ASCENT guide, or receiving the ASCENT guide plus video or phone calls with a community health worker or pain care manager.
- What's involved
- You will complete questionnaires and potentially have your electronic health records reviewed. If in one group, you will attend three 30-minute video or phone calls with a community health worker or pain care manager.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your pain score will be measured at baseline, 3 months, and 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors
At a glance
Conditions
NCT06198010
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Mayo Clinic in Arizona
Scottsdale, Arizonano site contact published
Mayo Clinic in Rochester
Rochester, Minnesotano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Andrea L. Cheville, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic in Rochester
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Pain ScoreBaseline, 3 months, 6 months
Will be measured using the Brief Pain Inventory Short Form (BPI SF), a 4-item questionnaire answered on a scale from 0 (no pain) to 10 (pain as bad as you can imagine). A higher score indicates worse pain.